|
Volumn 20, Issue 2, 2015, Pages 193-196
|
Thrombophilia
|
Author keywords
hypercoagulable state; thrombophilia; vascular diseases; venous thromboembolism
|
Indexed keywords
ACTIVATED PROTEIN C;
BLOOD CLOTTING FACTOR 5 LEIDEN;
CARDIOLIPIN ANTIBODY;
PHOSPHOLIPID ANTIBODY;
PROTEIN S;
PROTHROMBIN;
BLOOD CLOTTING FACTOR 5;
FIBRINOLYTIC AGENT;
ARTICLE;
BIRTH CONTROL;
DEEP VEIN THROMBOSIS;
ESTROGEN THERAPY;
FAMILY HISTORY;
GENE MUTATION;
HEART INFARCTION;
HORMONE SUBSTITUTION;
HUMAN;
MENOPAUSE;
PRIORITY JOURNAL;
RISK FACTOR;
THROMBOPHILIA;
TREATMENT DURATION;
HEMOSTASIS;
METABOLISM;
PHYSIOLOGY;
THROMBOEMBOLISM;
FACTOR V;
FIBRINOLYTIC AGENTS;
HEMOSTASIS;
HUMANS;
THROMBOEMBOLISM;
THROMBOPHILIA;
|
EID: 84926312073
PISSN: 1358863X
EISSN: 14770377
Source Type: Journal
DOI: 10.1177/1358863X15575769 Document Type: Article |
Times cited : (15)
|
References (6)
|